Similar articles

• Pharmacokinetics of pancuronium in patients with normal and impaired renal function.

  McLeod K, Watson MJ, Rawlins MD. McLeod K, et al. Br J Anaesth. 1976 Apr;48(4):341-5. doi: 10.1093/bja/48.4.341. Br J Anaesth. 1976. PMID: 1276000
• [Use of Pavulon in renal insufficiency patients].

  Tornos Solano D. Tornos Solano D. Rev Esp Anestesiol Reanim. 1974 Jan;21(1):61-7. Rev Esp Anestesiol Reanim. 1974. PMID: 4594967 Spanish. No abstract available.
• Disposition and urinary excretion of vecuronium bromide in anesthetized patients with normal renal function or renal failure.

  Bencini AF, Scaf AH, Sohn YJ, Meistelman C, Lienhart A, Kersten UW, Schwarz S, Agoston S. Bencini AF, et al. Anesth Analg. 1986 Mar;65(3):245-51. Anesth Analg. 1986. PMID: 2869722
• Proceedings: Pancuronium bromide (Pavulon, Organon). A new non-depolarizing neuromuscular blocker.

  Ezi-Ashi TI. Ezi-Ashi TI. West Afr J Pharmacol Drug Res. 1975 Jun;2(1):79P. West Afr J Pharmacol Drug Res. 1975. PMID: 1226750 No abstract available.
• Plasma binding of pancuronium: effects of age, sex, and disease.

  Wood M, Stone WJ, Wood AJ. Wood M, et al. Anesth Analg. 1983 Jan;62(1):29-32. Anesth Analg. 1983. PMID: 6849508